课题基金 / 基金详情

Translational Research in Cancer

Translational Research in Cancer
癌症转化研究
批准号:
8738098
负责人:
RICHARD G PESTELL
金额:
$7.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-06-18 至 2018-05-31

项目摘要

项目成果

RICHARD G PESTELL的其他基金

相似基金

相关文献

中文摘要
翻译
本癌症中心支持拨款(CCSG)提案要求资助Kimmel癌症中心(KCC)的癌症研究活动,以通过将基础研究发现转化为预防、诊断、监测和治疗人类癌症的新策略,提高癌症患者的生存率和生活质量。Kimmel癌症中心的主要任务是发现和翻译癌症遗传学、细胞生物学、生物化学和免疫学的最新发现,并将其转化为治疗癌症的新方法。
英文摘要
This proposal for a Cancer Center Support Grant (CCSG) requests funding to support the cancer research activities of the Kimmel Cancer Center (KCC), in order to increase the survival and quality of life of cancer patients by translating basic research discoveries into new strategies to prevent, diagnose, monitor and cure human cancer. The major thrust of the Kimmel Cancer Center is in discovery and translation of the latest findings in the genetics, cell biology, biochemistry and immunology of cancer into novel modalities to cure cancer. The Kimmel Cancer Center consists of six programs and thirteen shared resources to support the research programs. Investigators in each program are involved in intra-programmatic and interprogrammatic collaborations and have been extremely successful in obtaining peer-reviewed funding for these collaborative studies. The environment within the KCC has facilitated numerous collaborative studies and publications that have contributed to im portant advances in cancer research. The KCC programs are supported by $78.3M in total sponsored funding. Funding comes from 73 NCI sponsored projects, including 2 inter-programmatic NCI program project grants, and totals $34.4M. The efforts of the Director and his recruits have resulted in increased philanthropic University and Hospital support. The importance of cancer research and care at Thomas Jefferson University is reflected in the Director's authority over clinical and research activities at the Institution, encompassing 144,208 sq. ft, and the construction of new facilities (232,114 sq. ft) including the new Breast Center, Oncology Center and research space. These new facilities will accommodate the basic, clinical and translational efforts of the KCC investigators. These new KCC facilities will enhance even further the translational cancer research effort of the Kimmel Cancer Center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CCR5 inhibitors to enhance therapeutic response of breast cancer to DNA damaging agents
  • 批准号:
    10057534
  • 项目类别:
  • 资助金额:
    $38.28万
  • 财政年份:
    2020
  • 负责人:
    RICHARD G PESTELL
  • 依托单位:
Molecular Biology and Genetics Program
  • 批准号:
    8753662
  • 项目类别:
  • 资助金额:
    $3.0万
  • 财政年份:
    2014
  • 负责人:
    RICHARD G PESTELL
  • 依托单位:
Developmental Funds
  • 批准号:
    8302938
  • 项目类别:
  • 资助金额:
    $35.16万
  • 财政年份:
    2011
  • 负责人:
    RICHARD G PESTELL
  • 依托单位:
Radiation Research and Therapeutics
  • 批准号:
    8302934
  • 项目类别:
  • 资助金额:
    $3.11万
  • 财政年份:
    2011
  • 负责人:
    RICHARD G PESTELL
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: